| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3356734 | Indian Journal of Rheumatology | 2013 | 6 Pages |
Abstract
The treatment of renal AAV involves the use of steroids in combination with other immunosuppressive agents like cyclophosphamide to induce remission followed by maintenance therapy with a less potent agent like azathioprine. Plasmapharesis has a definite role especially in presence of renal failure while Rituximab is emerging as a promising alternative for remission induction.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
Subramanian Shankar, Abhishek Pathak, Rohit Tewari,